{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:53:30Z","timestamp":1791658410048,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700496"],"award-info":[{"award-number":["81700496"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018754","name":"Science and Technology Plan Projects of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["JJKT2020014"],"award-info":[{"award-number":["JJKT2020014"]}],"id":[{"id":"10.13039\/501100018754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Key Laboratory","award":["BZ0371"],"award-info":[{"award-number":["BZ0371"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Tibetan medicine has been used in clinical practice for more than 3800\u00a0years. Zuozhu-Daxi (ZZDX), a classic traditional Tibetan medicine, has been proved to be effective in the treatment of digestive diseases, such as chronic gastritis, gastric ulcer, etc.<jats:italic>Helicobacter pylori<\/jats:italic>(<jats:italic>H. pylori<\/jats:italic>), one of the most common pathogenic microbes, is regarded as the most common cause of gastritis. Researching on the effects of ZZDX on<jats:italic>H. pylori<\/jats:italic>-induced gastric mucosa inflammation could provide more evidences on<jats:italic>H. pylori<\/jats:italic>treatment and promote the development of Tibetan medicine. This study aimed to explore whether ZZDX could rescue<jats:italic>H. pylori<\/jats:italic>-induced gastric mucosa inflammation and its mechanism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Male C57BL\/6 mice were infected with<jats:italic>H. pylori<\/jats:italic>, and orally treated with ZZDX to rescue gastric mucosa inflammation induced by<jats:italic>H. pylori<\/jats:italic>infection. Pathology of gastric mucosa inflammation was evaluated under microscopy by hematoxylin\u2013eosin (HE) staining. The infection status of<jats:italic>H. pylori<\/jats:italic>was evaluated by immunohistochemical (IHC) staining. The reactive oxygen species (ROS) level in serum was evaluated using a detection kit. IL-1\u03b1, IL-6, and PGE2 expression levels in serum were measured using ELISA. IL-1\u03b1, IL-8, TNF-\u03b1, and NOD1 expression levels in gastric tissues were measured using real-time PCR. RNA sequencing and gene certification of interest were performed to explore the mechanisms in vivo and in vitro.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed that ZZDX could significantly inhibit<jats:italic>H. pylori<\/jats:italic>-induced gastric mucosa inflammation using HE staining. IL-1\u03b1, IL-6, and PGE2 expression levels in serum were significantly decreased after treatment with ZZDX. ZZDX treatment significantly decreased the mRNA expression of IL-8 induced by<jats:italic>H. pylori<\/jats:italic>infection in gastric tissues.<jats:italic>Elovl4, Acot1<\/jats:italic>and<jats:italic>Scd1<\/jats:italic>might be involved in the mechanisms of ZZDX treatment. However, the<jats:italic>H. pylori<\/jats:italic>infection status in the gastric mucosa was not reduced after ZZDX treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ZZDX reversed gastric mucosal injury and alleviated gastric mucosa inflammation induced by<jats:italic>H. pylori<\/jats:italic>infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13020-022-00682-9","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T06:02:36Z","timestamp":1667887356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The tibetan medicine Zuozhu-Daxi can prevent Helicobacter pylori induced-gastric mucosa inflammation by inhibiting lipid metabolism"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanyan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsang","family":"Norbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"2","key":"682_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420\u20139.","journal-title":"Gastroenterology"},{"issue":"1","key":"682_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/his.14245","volume":"78","author":"J Jessurun","year":"2021","unstructured":"Jessurun J. Helicobacter pylori: an evolutionary perspective. Histopathology. 2021;78(1):39\u201347.","journal-title":"Histopathology"},{"issue":"Pt 3","key":"682_CR3","first-page":"951","volume":"86","author":"JG Navashenaq","year":"2021","unstructured":"Navashenaq JG, Shabgah AG, Banach M, et al. The interaction of helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol. 2021;86(Pt 3):951\u20139.","journal-title":"Semin Cancer Biol."},{"issue":"18","key":"682_CR4","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.3748\/wjg.v20.i18.5461","volume":"20","author":"J Watari","year":"2014","unstructured":"Watari J, Chen N, Amenta PS, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461\u201373.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"682_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in helicobacter pylori: a systematic review and meta-analysis in world health organization regions. Gastroenterology. 2018;155(5):1372-1382.e1317.","journal-title":"Gastroenterology"},{"issue":"3","key":"682_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12799","volume":"26","author":"Y Li","year":"2021","unstructured":"Li Y, Li X, Tan Z. An overview of traditional Chinese medicine therapy for Helicobacter pylori-related gastritis. Helicobacter. 2021;26(3): e12799.","journal-title":"Helicobacter"},{"issue":"2","key":"682_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12475","volume":"23","author":"WZ Liu","year":"2018","unstructured":"Liu WZ, Xie Y, Lu H, et al. Fifth Chinese national consensus report on the management of helicobacter pylori infection. Helicobacter. 2018;23(2): e12475.","journal-title":"Helicobacter"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"4320219","DOI":"10.1155\/2018\/4320219","volume":"2018","author":"L Li","year":"2018","unstructured":"Li L, Meng F, Zhu S, et al. Efficacy and safety of Wei Bi Mei, a Chinese herb compound, as an alternative to bismuth for eradication of helicobacter pylori. Evid Based Complement Alternat Med. 2018;2018:4320219.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"35","key":"682_CR9","doi-asserted-by":"publisher","first-page":"10781","DOI":"10.12998\/wjcc.v9.i35.10781","volume":"9","author":"RJ Li","year":"2021","unstructured":"Li RJ, Dai YY, Qin C, et al. Application of traditional Chinese medicine in treatment of Helicobacter pylori infection. World J Clin Cases. 2021;9(35):10781\u201391.","journal-title":"World J Clin Cases"},{"issue":"3","key":"682_CR10","first-page":"149","volume":"16","author":"E Zuskin","year":"2008","unstructured":"Zuskin E, Lipozenci\u0107 J, Pucarin-Cvetkovi\u0107 J, et al. Ancient medicine\u2013a review. Acta Dermatovenerol Croat. 2008;16(3):149\u201357.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"682_CR11","first-page":"7","volume":"28","author":"J Hai","year":"2022","unstructured":"Hai J. Effect of western medicine triple combination combined with Tibetan medicine Zuozhu-Daxi pill on improving gastrointestinal function and serum CRP and IL-4 levels in the treatment of peptic ulcer. Chin J Ethnic Med. 2022;28(2):7\u20138.","journal-title":"Chin J Ethnic Med"},{"issue":"8","key":"682_CR12","first-page":"1500","volume":"32","author":"W Hu","year":"2011","unstructured":"Hu W. Clinical observation on the treatment of digestive tract tumor vomiting after chemotherapy with Zuozhu-Daxi combined with Astragalus injection and Xiaobanxia pill. Jilin Medical J. 2011;32(8):1500\u20131.","journal-title":"Jilin Medical J"},{"issue":"4","key":"682_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/cells9041055","volume":"9","author":"J Baj","year":"2020","unstructured":"Baj J, Korona-Glowniak I, Forma A, et al. Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in helicobacter pylori-induced gastric cancer. Cells. 2020;9(4):1055.","journal-title":"Cells."},{"issue":"Suppl","key":"682_CR14","first-page":"1","volume":"22","author":"V Camilo","year":"2017","unstructured":"Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl):1.","journal-title":"Helicobacter"},{"issue":"19","key":"682_CR15","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.3390\/molecules26196078","volume":"26","author":"IA Cardos","year":"2021","unstructured":"Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting therapeutic strategies for H. pylori treatment in the context of antibiotic resistance focus on alternative and complementary therapies. Molecules. 2021;26(19):6078.","journal-title":"Molecules"},{"issue":"11","key":"682_CR16","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2174\/1389450121999201230204526","volume":"22","author":"R Varghese","year":"2021","unstructured":"Varghese R, Dalvi YB. Natural products as anticancer agents. Curr Drug Targets. 2021;22(11):1272\u201387.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"682_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/cmdc.202000771","volume":"16","author":"L Winand","year":"2021","unstructured":"Winand L, Sester A, Nett M. Bioengineering of anti-inflammatory natural products. ChemMedChem. 2021;16(5):767\u201376.","journal-title":"ChemMedChem"},{"issue":"1","key":"682_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/13813455.2019.1610779","volume":"127","author":"WH El-Tantawy","year":"2021","unstructured":"El-Tantawy WH. Natural products for the management of hyperuricaemia and gout: a review. Arch Physiol Biochem. 2021;127(1):61\u201372.","journal-title":"Arch Physiol Biochem"},{"issue":"6","key":"682_CR19","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/ptr.7002","volume":"35","author":"S Zhang","year":"2021","unstructured":"Zhang S, Li L, Chen W, Xu S, Feng X, Zhang L. Natural products: the role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res. 2021;35(6):2945\u201367.","journal-title":"Phytother Res"},{"issue":"2","key":"682_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ptr.6873","volume":"35","author":"M Boozari","year":"2021","unstructured":"Boozari M, Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2021;35(2):864\u201376.","journal-title":"Phytother Res"},{"issue":"5","key":"682_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1389450121666200924113740","volume":"22","author":"NB Sadeer","year":"2021","unstructured":"Sadeer NB, Mahomoodally MF. Antibiotic potentiation of natural products: a promising target to fight pathogenic bacteria. Curr Drug Targets. 2021;22(5):555\u201372.","journal-title":"Curr Drug Targets"},{"key":"682_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112502","volume":"202","author":"S Yuan","year":"2020","unstructured":"Yuan S, Gopal JV, Ren S, Chen L, Liu L, Gao Z. Anticancer fungal natural products: mechanisms of action and biosynthesis. Eur J Med Chem. 2020;202: 112502.","journal-title":"Eur J Med Chem"},{"key":"682_CR23","first-page":"4","volume":"23","author":"H Wang","year":"2014","unstructured":"Wang H. Talk shallowly that on the clinical application of Tibetan medicine Zuozhu Daxi. Chin J Ethnomed and Ethnopharm. 2014;23:4\u20135.","journal-title":"Chin J Ethnomed and Ethnopharm"},{"issue":"3","key":"682_CR24","first-page":"417","volume":"32","author":"F Shen","year":"2022","unstructured":"Shen F, Li X, Qi D, Jiang H, Guo Z, Chen P. Relationship between the genotypes of Helicobacter pylori in fection and gastroin testinal diseases. Chin J Nosocomiology. 2022;32(3):417\u201321.","journal-title":"Chin J Nosocomiology"},{"issue":"1","key":"682_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/cmi.2016.34","volume":"14","author":"D Bertheloot","year":"2017","unstructured":"Bertheloot D, Latz E. HMGB1, IL-1\u03b1, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol. 2017;14(1):43\u201364.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"682_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1099\/jmm.0.001088","volume":"69","author":"B Zeng","year":"2020","unstructured":"Zeng B, Chen C, Yi Q, et al. N-terminal region of Helicobacter pylori CagA induces IL-8 production in gastric epithelial cells via the \u03b21 integrin receptor. J Med Microbiol. 2020;69(3):457\u201364.","journal-title":"J Med Microbiol"},{"issue":"3","key":"682_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/toxins13030181","volume":"13","author":"M Suganuma","year":"2021","unstructured":"Suganuma M, Watanabe T, Sueoka E, Lim IK, Fujiki H. Role of TNF-\u03b1-inducing protein secreted by helicobacter pylori as a tumor promoter in gastric cancer and emerging preventive strategies. Toxins. 2021;13(3):181.","journal-title":"Toxins."},{"issue":"7","key":"682_CR28","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1158\/0008-5472.CAN-18-2651","volume":"79","author":"G Suarez","year":"2019","unstructured":"Suarez G, Romero-Gallo J, Piazuelo MB, et al. Nod1 imprints inflammatory and carcinogenic responses toward the gastric pathogen helicobacter pylori. Cancer Res. 2019;79(7):1600\u201311.","journal-title":"Cancer Res"},{"issue":"18","key":"682_CR29","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.3748\/wjg.v20.i18.5235","volume":"20","author":"CA Figueiredo","year":"2014","unstructured":"Figueiredo CA, Marques CR, Costa Rdos S, da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol. 2014;20(18):5235\u201343.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"682_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/cei.13200","volume":"194","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wang X, Yu Y, et al. Serum exosomes of chronic gastritis patients infected with Helicobacter pylori mediate IL-1\u03b1 expression via IL-6 trans-signalling in gastric epithelial cells. Clin Exp Immunol. 2018;194(3):339\u201349.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"682_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120938","volume":"10","author":"D Cao","year":"2015","unstructured":"Cao D, Jiang J, Tsukamoto T, et al. Canolol inhibits gastric tumors initiation and progression through COX-2\/PGE2 pathway in K19\u2013C2mE transgenic mice. PLoS ONE. 2015;10(3): e0120938.","journal-title":"PLoS ONE"},{"issue":"3","key":"682_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1159\/000430261","volume":"36","author":"W Gehrmann","year":"2015","unstructured":"Gehrmann W, W\u00fcrdemann W, Pl\u00f6tz T, J\u00f6rns A, Lenzen S, Elsner M. Antagonism between saturated and unsaturated fatty acids in ROS mediated lipotoxicity in rat insulin-producing cells. Cell Physiol Biochem. 2015;36(3):852\u201365.","journal-title":"Cell Physiol Biochem"},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-3-319-91287-5_63","volume":"1072","author":"S Trommer","year":"2018","unstructured":"Trommer S, Leimert A, Bucher M, Schumann J. Polyunsaturated fatty acids induce ROS synthesis in microvascular endothelial cells. Adv Exp Med Biol. 2018;1072:393\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"682_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpb.2020.110408","volume":"242","author":"P Sun","year":"2020","unstructured":"Sun P, Zhou Q, Monroig \u00d3, et al. Cloning and functional characterization of an elovl4-like gene involved in the biosynthesis of long-chain polyunsaturated fatty acids in the swimming crab Portunus trituberculatus. Comp Biochem Physiol B Biochem Mol Biol. 2020;242: 110408.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"1","key":"682_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12951-021-00810-x","volume":"19","author":"S Duan","year":"2021","unstructured":"Duan S, Zhang M, Li J, et al. Uterine metabolic disorder induced by silica nanoparticles: biodistribution and bioactivity revealed by labeling with FITC. J Nanobiotechnology. 2021;19(1):62.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"682_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12863-020-0829-6","volume":"21","author":"Z Li","year":"2020","unstructured":"Li Z, Lu S, Cui K, et al. Fatty acid biosynthesis and transcriptional regulation of Stearoyl-CoA Desaturase 1 (SCD1) in buffalo milk. BMC Genet. 2020;21(1):23.","journal-title":"BMC Genet"},{"key":"682_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-0-387-74904-4_33","volume":"613","author":"V Vasireddy","year":"2008","unstructured":"Vasireddy V, Sharon M, Salem N Jr, Ayyagari R. Role of ELOVL4 in fatty acid metabolism. Adv Exp Med Biol. 2008;613:283\u201390.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"682_CR38","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.21037\/tcr-22-168","volume":"11","author":"Y Yang","year":"2022","unstructured":"Yang Y, Chen Z, Zhou L, et al. In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. Transl Cancer Res. 2022;11(7):1977\u201393.","journal-title":"Transl Cancer Res"},{"key":"682_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.humpath.2018.03.013","volume":"77","author":"F Wang","year":"2018","unstructured":"Wang F, Wu J, Qiu Z, et al. ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma. Hum Pathol. 2018;77:35\u201344.","journal-title":"Hum Pathol"},{"issue":"9","key":"682_CR40","doi-asserted-by":"publisher","first-page":"8871","DOI":"10.1007\/s11033-021-07094-2","volume":"49","author":"M Raeisi","year":"2022","unstructured":"Raeisi M, Hassanbeigi L, Khalili F, Kharrati-Shishavan H, Yousefi M, Mehdizadeh A. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma. Mol Biol Rep. 2022;49(9):8871\u201382.","journal-title":"Mol Biol Rep"},{"issue":"15","key":"682_CR41","doi-asserted-by":"publisher","first-page":"15374","DOI":"10.18632\/aging.103598","volume":"12","author":"C Wang","year":"2020","unstructured":"Wang C, Shi M, Ji J, et al. Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer. Aging. 2020;12(15):15374\u201391.","journal-title":"Aging"},{"issue":"1","key":"682_CR42","first-page":"10","volume":"6","author":"F Huang","year":"2000","unstructured":"Huang F, Ren W, Yang G. Clinical observation on therapeutic efficiency of tibean medicine used in treating atrophic gastritis. Chin J of Ethnic Med. 2000;6(1):10\u20132.","journal-title":"Chin J of Ethnic Med"},{"issue":"z2","key":"682_CR43","first-page":"61","volume":"35","author":"G Yu","year":"2012","unstructured":"Yu G, Tan Y. Clinical observation of combined treatment of Helicobacter pylori positive peptic ulcer with Zuozhu-Daxi. Chin J Adv Med Educ. 2012;35(z2):61\u20132.","journal-title":"Chin J Adv Med Educ"},{"issue":"9","key":"682_CR44","first-page":"34","volume":"20","author":"M Hu","year":"2014","unstructured":"Hu M, Zhou H, Wang M, Chen C, Du Y. Recent development of study on mongolian medicine gypsum fibrosum. J Med Pharm of Chin Mnorities. 2014;20(9):34\u20136.","journal-title":"J Med Pharm of Chin Mnorities"},{"key":"682_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788558","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Wang Q, Chen P, Zhou C, Zhang X, Chen L. Ursodeoxycholic acid treatment restores gut microbiota and alleviates liver inflammation in non-alcoholic steatohepatitic mouse model. Front Pharmacol. 2021;12: 788558.","journal-title":"Front Pharmacol"},{"issue":"3","key":"682_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0006-2952(01)00917-0","volume":"63","author":"X Chen","year":"2002","unstructured":"Chen X, Mellon RD, Yang L, Dong H, Oppenheim JJ, Howard OM. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol. 2002;63(3):533\u201341.","journal-title":"Biochem Pharmacol"},{"key":"682_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106355","volume":"82","author":"S Yu","year":"2020","unstructured":"Yu S, Zhao G, Han F, et al. Muscone relieves inflammatory pain by inhibiting microglial activation-mediated inflammatory response via abrogation of the NOX4\/JAK2-STAT3 pathway and NLRP3 inflammasome. Int Immunopharmacol. 2020;82: 106355.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"682_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.intimp.2012.08.011","volume":"14","author":"J Chun","year":"2012","unstructured":"Chun J, Choi RJ, Khan S, et al. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-\u03baB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int Immunopharmacol. 2012;14(4):375\u201383.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"682_CR49","first-page":"298","volume":"18","author":"M Luo","year":"2012","unstructured":"Luo M, Li C, Lin L, Wang Z, Guo W. Research progress on tibetan medicinal herb ponkar. Chin J Exp Tradit Med Formulae. 2012;18(12):298\u2013302.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"06","key":"682_CR50","first-page":"77","volume":"27","author":"Y Du","year":"2013","unstructured":"Du Y, Wang X, Yang M. Advances in pharmacological activities of the medicinal plants of genus Veronica. Chin Med J Res Prac. 2013;27(06):77\u201380.","journal-title":"Chin Med J Res Prac"},{"issue":"5","key":"682_CR51","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/jpn.13612","volume":"106","author":"L Cai","year":"2022","unstructured":"Cai L, Wei Z, Zhao X, Li Y, Li X, Jiang X. Gallic acid mitigates LPS-induced inflammatory response via suppressing NF-\u03baB signalling pathway in IPEC-J2 cells. J Anim Physiol Anim Nutr (Berl). 2022;106(5):1000\u20138.","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"issue":"3","key":"682_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jep.2006.07.021","volume":"107","author":"K Sch\u00fctz","year":"2006","unstructured":"Sch\u00fctz K, Carle R, Schieber A. Taraxacum\u2013a review on its phytochemical and pharmacological profile. J Ethnopharmacol. 2006;107(3):313\u201323.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"682_CR53","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1002\/ptr.7158","volume":"35","author":"NP Shetty","year":"2021","unstructured":"Shetty NP, Prabhakaran M, Srivastava AK. Pleiotropic nature of curcumin in targeting multiple apoptotic-mediated factors and related strategies to treat gastric cancer: a review. Phytother Res. 2021;35(10):5397\u2013416.","journal-title":"Phytother Res"},{"issue":"18","key":"682_CR54","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/14786419.2019.1682576","volume":"35","author":"CS Alaribe","year":"2021","unstructured":"Alaribe CS, Esposito T, Sansone F, et al. Nigerian propolis: chemical composition, antioxidant activity and alpha-amylase and alpha-glucosidase inhibition. Nat Prod Res. 2021;35(18):3095\u20139.","journal-title":"Nat Prod Res"},{"issue":"3","key":"682_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/molecules25030586","volume":"25","author":"I Korona-Glowniak","year":"2020","unstructured":"Korona-Glowniak I, Glowniak-Lipa A, Ludwiczuk A, Baj T, Malm A. The in vitro activity of essential oils against helicobacter pylori growth and urease activity. Molecules. 2020;25(3):586.","journal-title":"Molecules"},{"issue":"8","key":"682_CR56","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/molecules26082272","volume":"26","author":"H Ullah","year":"2021","unstructured":"Ullah H, Di Minno A, Santarcangelo C, et al. Vegetable extracts and nutrients useful in the recovery from helicobacter pylori infection: a systematic review on clinical trials. Molecules. 2021;26(8):2272.","journal-title":"Molecules"},{"issue":"1","key":"682_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2991\/efood.k.200211.001","volume":"1","author":"LS Wang","year":"2020","unstructured":"Wang LS, Echeveste CE, Yu J, et al. Can natural products suppress resistant helicobacter pylori to fight against gastric diseases in humans. eFood. 2020;1(1):53\u201360.","journal-title":"eFood"},{"issue":"23","key":"682_CR58","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1007\/s00253-020-10945-w","volume":"104","author":"P Roszczenko-Jasinska","year":"2020","unstructured":"Roszczenko-Jasinska P, Wojtys MI, Jagusztyn-Krynicka EK. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets. Appl Microbiol Biotechnol. 2020;104(23):9891\u2013905.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"37","key":"682_CR59","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.3748\/wjg.15.4715","volume":"15","author":"J Lin","year":"2009","unstructured":"Lin J, Huang WW. A systematic review of treating Helicobacter pylori infection with traditional Chinese medicine. World J Gastroenterol. 2009;15(37):4715\u20139.","journal-title":"World J Gastroenterol"},{"key":"682_CR60","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3389\/fphar.2019.01694","volume":"10","author":"Q Hu","year":"2019","unstructured":"Hu Q, Peng Z, Li L, et al. The efficacy of berberine-containing quadruple therapy on helicobacter pylori eradication in china: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2019;10:1694.","journal-title":"Front Pharmacol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-022-00682-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T17:26:04Z","timestamp":1728321964000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-022-00682-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s13020-022-00682-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Peking University Biomedical Ethics Committee, Laboratory Animal Welfare Ethics Branch (Ethics approval number for the use of animals in this study was LA2019343).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that the Publisher has the authors\u2019 permission to publish the relevant contribution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publishlication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}